Patents by Inventor Christiane Gerke

Christiane Gerke has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11986518
    Abstract: This invention relates to immunogenic compositions, particularly vaccine compositions, for use in providing protection against illness caused by bacterial infection with Shigella strains.
    Type: Grant
    Filed: August 5, 2020
    Date of Patent: May 21, 2024
    Assignee: GLAXOSMITHKLINE BIOLOGICALS SA
    Inventors: Christiane Gerke, Laura Bartle Martin, Allan James Saul
  • Publication number: 20230021583
    Abstract: The invention relates to the field of immunity against Coronaviruses. In this respect, the invention provides vectorized antigens derived from Coronaviruses that trigger an immune response against Coronaviruses. The invention accordingly relates to an active ingredient which is a live attenuated recombinant measles virus expressing Coronavirus antigen(s) and to its use in eliciting immunity, in particular protective immunity against SARS-CoV-2 strain and advantageously broad-spectrum protective immunity against various strains of Coronaviruses.
    Type: Application
    Filed: February 12, 2021
    Publication date: January 26, 2023
    Inventors: NICOLAS Robert, Xavier ESCRIOU, FREDERIC TANGY, CHRISTIANE GERKE
  • Patent number: 11339367
    Abstract: Hyperblebbing Shigella strains are generated by disrupting one or more components of the Tol-Pal system. The blebs from these strains are useful immunogens for vaccination. The individual proteins found in these blebs can also be used as immunogens.
    Type: Grant
    Filed: April 8, 2016
    Date of Patent: May 24, 2022
    Assignee: GLAXOSMITHKLINE BIOLOGICALS SA
    Inventors: Christiane Gerke, Francesco Berlanda Scorza, Allan Saul, Luana Maggiore
  • Publication number: 20200384096
    Abstract: This invention relates to immunogenic compositions, particularly vaccine compositions, for use in providing protection against illness caused by bacterial infection with Shigella strains.
    Type: Application
    Filed: August 5, 2020
    Publication date: December 10, 2020
    Applicant: GLAXOSMITHKLINE BIOLOGICALS SA
    Inventors: Christiane GERKE, Laura Bartle MARTIN, Allan James SAUL
  • Publication number: 20180169206
    Abstract: This invention relates to immunogenic compositions, particularly vaccine compositions, for use in providing protection against illness caused by bacterial infection with Shigella strains.
    Type: Application
    Filed: June 15, 2016
    Publication date: June 21, 2018
    Applicant: GLAXOSMITHKLINE BIOLOGICALS, SA
    Inventors: Christiane GERKE, Laura Bartle MARTIN, Allan James SAUL
  • Publication number: 20160289632
    Abstract: Hyperblebbing Shigella strains are generated by disrupting one or more components of the Tol-Pal system. The blebs from these strains are useful immunogens for vaccination. The individual proteins found in these blebs can also be used as immunogens.
    Type: Application
    Filed: April 8, 2016
    Publication date: October 6, 2016
    Inventors: Christiane Gerke, Francesco Berlanda Scorza, Allan Saul, Luana Maggiore
  • Publication number: 20130052227
    Abstract: Hyperblebbing Shigella strains are generated by disrupting one or more components of the Tol-Pal system. The blebs from these strains are useful immunogens for vaccination. The individual proteins found in these blebs can also be used as immunogens.
    Type: Application
    Filed: September 28, 2010
    Publication date: February 28, 2013
    Applicant: Novartis Vaccines Institute For Global Health S.R.L.
    Inventors: Christiane Gerke, Francesco Berlanda Scorza, Allan Saul, Luana Maggiore